Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events - Concepedia

Concepedia

Publication | Closed Access

Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events

25

Citations

0

References

2022

Year

Michie Katsuta, TAKAHIRO KIMURA, Kojiro Tashiro, Masaya Murakami, Kenichi Hata, Takafumi Yanagisawa, Hajime Onuma, Toshihiro Yamamoto, Shingo Sugaya, YOSHINORI WATANABE,

Anticancer Research

Abstract

A lower body weight is a significant risk factor for apalutamide-related cutaneous adverse events and their onset is within 6 months of initiation of therapy.